Roivant Sciences Ltd. insider Daniel Allen Gold sells $53.5M in ROIV shares
An open-market sale between Nov 16 and Nov 17, reported to the SEC on Nov 18, not marked as part of a 10b5-1 plan.
Daniel Allen Gold, a director of Roivant Sciences Ltd. (ROIV), sold 1,381,762 shares between Nov 16 and Nov 17 at an average price of $38.75, a total of about $54 million, according to a Form 4 filed with the SEC on Nov 18.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. Four Roivant Sciences Ltd. insiders sold on the open market within 14 days, a pattern known as a cluster sell.
The trade was reported within two business days, as Section 16 requires. It is the 14th insider sale at Roivant Sciences Ltd. reported in the last 90 days.
Details from the SEC filing:
| Company | Roivant Sciences Ltd. (ROIV) |
|---|---|
| Insider | Daniel Allen Gold |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 1,381,762 |
| Average price | $38.75 |
| Value | $53,536,738 |
| Trade dates | Nov 16 to Nov 17, 2026 |
| Filed with the SEC | Nov 18, 2026, 6:04 PM ET |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this ROIV sale
Follow ROIV for the next insider trade · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.